Post job

Amicus Therapeutics overview

Industry
Biotechnology
Revenue
Headquarters
Employees
508
Founded in
Website
Organization type
Public
Social media
Amicus Therapeutics (Nasdaq:FOLD) is a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases. The Company has a robust pipeline of novel, first-in-class, small molecules called pharmacological chaperones for the treatment of lysosomal storage diseases (LSDs). These chaperones may offer a dual-treatment approach for Fabry, Pompe, Gaucher and other LSDs. As orally administered monotherapy agents, pharmacological chaperones are designed to bind to, stabilize and increase the activity of a patient's own misfolded enzyme. In combination with enzyme replacement therapy (ERT), pharmacological chaperones may improve the uptake of the infused enzyme and potentially improve ERT outcomes.
Founded in 2002, Amicus Therapeutics is an established company that loves to hire graduates from Drexel University, with 14.3% of its employees having attended Drexel University. Amicus Therapeutics has established itself as a great place to work in New Jersey, and it is number 3 on Zippia's list of Best Companies to Work for in Cranbury, NJ.The average employee at Amicus Therapeutics makes $88,124 per year. In comparison, some of its highest paying competitors, like Gilead Sciences, Genentech, and Onyx Pharmaceuticals, pay $99,828, $97,473, and $95,378, respectively.
Amicus Therapeutics is a medium health care company with 508 employees and an annual revenue of $528.3M that is headquartered in New Jersey.

Amicus Therapeutics's mission statement

To make medicines that improve the lives of patients living with rare disease.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration

4.0/5

Amicus Therapeutics employee reviews

Based on 1 ratings

Do you work at Amicus Therapeutics?

Help job seekers learn about working at Amicus Therapeutics

On this page

Be the first to review Amicus Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Amicus Therapeutics?

The team at Amicus Therapeutics

  • The founders of Amicus Therapeutics is John Francis Crowley.
  • The key people at Amicus Therapeutics is John Francis Crowley.
Key people
John Francis Crowley

Amicus Therapeutics rankings

Amicus Therapeutics is ranked #20 on the Best Health Care companies to work for in New Jersey list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Amicus Therapeutics salaries

Average Amicus Therapeutics salary
$88,124
yearly
$42.37 hourly
Updated March 14, 2024

Rate Amicus Therapeutics' commitment to diversity and inclusion.

Zippia waving zebra

Amicus Therapeutics diversity

8.8
Diversity score
We calculated Amicus Therapeutics’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Amicus Therapeutics’s workforce.
Amicus Therapeutics diversity summary. Zippia estimates Amicus Therapeutics's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Amicus Therapeutics's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Amicus Therapeutics's workforce.
  • Amicus Therapeutics has 508 employees.
  • 57% of Amicus Therapeutics employees are women, while 43% are men.
  • The most common ethnicity at Amicus Therapeutics is White (47%).
  • 21% of Amicus Therapeutics employees are Asian.
  • 17% of Amicus Therapeutics employees are Hispanic or Latino.
  • The average employee at Amicus Therapeutics makes $88,124 per year.
  • Employees at Amicus Therapeutics stay with the company for 3.9 years on average.

Do you work at Amicus Therapeutics?

Did Amicus Therapeutics' compensation package meet your expectations?

Amicus Therapeutics financial performance

9.7
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Amicus Therapeutics currently has 329.2M in revenue. Amicus Therapeutics's most recent quarter produced 94.5m (q2'2023).

Amicus Therapeutics annual revenue

$528M
$423M
$317M
$211M
$106M
$0
2019
2020
2021
2022
2023
2024

Highest paying Amicus Therapeutics competitors

Compare Amicus Therapeutics salaries to competitors, including Gilead Sciences, Genentech, and Onyx Pharmaceuticals. Employees at Gilead Sciences earn the highest average yearly salary of $99,828. The salaries at Genentech average $97,473 per year, and the salaries at Onyx Pharmaceuticals come in at $95,378 per year.
RankCompanyAverage salaryJobs
1$99,8280
2$97,4730
3$95,3780
4$94,1350
5$94,0780
6$93,3490
7$90,3280
8$87,2590
9$85,5890
10$85,0080

Are you an executive, HR leader, or brand manager at Amicus Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Amicus Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of Amicus Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Amicus Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Amicus Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Amicus Therapeutics. The data presented on this page does not represent the view of Amicus Therapeutics and its employees or that of Zippia.

Amicus Therapeutics may also be known as or be related to AMICUS THERAPEUTICS INC, Amicus Therapeutics, Amicus Therapeutics Inc, Amicus Therapeutics Inc. and Amicus Therapeutics, Inc.